PBM Stock Price Chart
PBM Financial
Psyence Biomedical Ltd
$3.1
4.37%
$0.12
At close: Jun 29, 16:00:00 GMT-4
$3.1
0%
$0
Post-market: Jun 29, 20:00:00 GMT-4
Back
Psyence Biomedical Ltd (PBM) Financial
Key Stats
Prev.Close
$2.97
Open
$2.95
Day's Range
$2.95 - $3.16
52 week range
$1.92 - $468.38
Volume
35.0K
Avg.Volume
1.8M
Dividend yield
--
EPS (TTM)
1612.60
Market Cap
$7.1M
What is PBM?
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
